STAT5 action on the lipid metabolism is partially mediated by CD36, a transporter of FFA that has a pivotal role in NAFLD due to the enhancement of FFA uptake and liver steatosis [39] (p. 36). Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.